Theravance Biopharma
TBPH
#6351
Rank
HK$6.93 B
Marketcap
Country
HK$133.50
Share price
0.00%
Change (1 day)
-3.26%
Change (1 year)

EPS for Theravance Biopharma (TBPH)

EPS in 2026 (TTM): HK$8.24

According to Theravance Biopharma 's latest financial reports the company's current EPS (TTM) is HK$8.31. In 2025 the company made an earnings per share (EPS) of HK$16.38 an increase over its 2024 EPS that were of -HK$9.01.

EPS history for Theravance Biopharma from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$8.24-49.74%
2025HK$16.38-281.74%
2024-HK$9.0118.56%
2023-HK$7.60-108.41%
2022HK$90.46-491.19%
2021-HK$23.12-34.15%
2020-HK$35.125.16%
2019-HK$33.396.5%
2018-HK$31.36-26.61%
2017-HK$42.7228.24%
2016-HK$33.32
2014-HK$58.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Corcept Therapeutics
CORT
HK$11.76 41.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Collegium Pharmaceutical
COLL
HK$9.56 15.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
HK$14.19 70.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
-HK$49.62-697.17%๐Ÿ‡บ๐Ÿ‡ธ USA